Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The real Erin Brockovich takes on Bayer's birth control
Mass Device
Thursday, October 17, 2013 - 9:58am
tags:
Essure, Bayer, contraceptives, devices
You Shouldn't Ignore Gilead's Idelalisib
Motley Fool
Thursday, October 17, 2013 - 9:54am
tags:
Gilead, idelalisab, indolent non-Hodgkin's lymphoma
CytRx Awaiting Soft Tissue Sarcoma Data In December
Seeking Alpha
Thursday, October 17, 2013 - 9:51am
tags:
CytRx, soft tissue sarcoma, aldoxorubicin
Actelion sales rise ahead of anticipated drug approval
Yahoo/Reuters
Thursday, October 17, 2013 - 9:40am
tags:
Actelion, earnings
Roche Quarterly Revenue Advances on Sales of Cancer Drugs
Bloomberg
Thursday, October 17, 2013 - 8:39am
tags:
Roche
David Schenkein, Cancer Doc Turned CEO, Aims to Build New Genentech
Xconomy
Thursday, October 17, 2013 - 8:36am
tags:
David Schenkein, Agios Pharmaceuticals, Genentech
Amarin: Dead Stock Walking With Negative Vascepa Panel Vote
TheStreet.com
Thursday, October 17, 2013 - 8:27am
tags:
Amarin, Vascepa, FDA, advisory panels
Dynavax: New Phase 3 Clinical Study Finalized For HEPLISAV
Seeking Alpha
Thursday, October 17, 2013 - 8:25am
tags:
Heplisav, Dynavax, vaccines, hepatitis B
Pfizer Receives European Approval For Label Update Regarding The Use Of Prevenar 13 In Certain High-Risk Populations
Yahoo
Thursday, October 17, 2013 - 8:25am
tags:
Pfizer, Europe, Prevnar 13, vaccines
3 Pipeline Drugs That Could Have a Dramatic Impact on Parkinson's Disease by 2020
Motley Fool
Thursday, October 17, 2013 - 8:24am
tags:
Parkinson's Disease, pimavanserin, Acadia, Duodopa, AbbVie, LCIG, AFQ056, Novartis
Galapagos sees cystic fibrosis clinical trials in 2014
Yahoo/Reuters
Thursday, October 17, 2013 - 8:22am
tags:
cystic fibrosis, Galapagos
[video]Roche looks to emerging markets for growth
CNBC
Thursday, October 17, 2013 - 8:21am
tags:
Roche, emerging markets, Severin Schwan
4 Ways GlaxoSmithKline plc Will Continue To Lag The Biotechnology Sector
Motley Fool
Thursday, October 17, 2013 - 8:20am
tags:
GSK
FDA panel rejects expanded use of Amarin's Vascepa amid questions for fish oil drug
Yahoo/AP
Wednesday, October 16, 2013 - 3:40pm
tags:
Amarin, FDA, advisory panels, Vascepa
Teva halts Israeli layoff plans amid pressure from labor, government
Fierce Pharma
Wednesday, October 16, 2013 - 11:37am
tags:
Teva, Israel, layoffs
CardioDx IPO may fetch $86.3 million
Mass Device
Wednesday, October 16, 2013 - 11:36am
tags:
devices, CardioDx, IPOs
A Small Cap Pharmaceutical That Is Making Money: Why Tianyin Is Severely Undervalued
Seeking Alpha
Wednesday, October 16, 2013 - 11:34am
tags:
Tianyin Pharmaceutical, China
Former Bayer Employee Can Proceed With Whistleblower Lawsuit
Pharmalot
Wednesday, October 16, 2013 - 11:03am
tags:
Bayer, Baycol, whistleblower lawsuits
Gilead’s Single Tablet HIV Regimen Stribild® Demonstrates Durable Viral Suppression Through Three Years of Therapy
Yahoo
Wednesday, October 16, 2013 - 10:59am
tags:
Giilead, HIV, Stribild
Cancer immunotherapies set to storm onto the market, analysts say
Fierce Biotech
Wednesday, October 16, 2013 - 10:03am
tags:
cancer immunotherapy, Merck, Roche, Bristol-Myers Squibb

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.